Analysis of hydrophilic and lipophilic choline compounds in radioresistant and radiosensitive glioblastoma cell lines by HILIC-ESI-MS/MS
- 25 September 2010
- journal article
- research article
- Published by Springer Nature in Analytical and Bioanalytical Chemistry
- Vol. 398 (6) , 2723-2730
Abstract
A new method based on hydrophilic interaction chromatography-electrospray ionisation–tandem mass spectrometry (HILIC-ESI-MS/MS) coupled to the use of a stable isotope labelled substrate was developed to study the metabolism of choline (Cho) compounds in two human glioblastoma multiform (GBM) cell lines with different responses to ionising radiation. Analysis was performed in the positive ion mode using multiple reaction monitoring. This fast, sensitive and selective method enabled the profiling of both hydrophilic and lipophilic Cho-containing compounds, to analyse specifically different phosphatidylcholine (PtdCho) molecular species, and to measure simultaneously native and labelled Cho metabolites. Radioresistant (SF763) and radiosensitive (SF767) cells were incubated for 8 h with d 9-Cho. Higher native Cho and phosphocholine (PCho) concentrations and higher uptake of d 9-Cho and formation of d 9-PCho were found in the radioresistant cell line. The similar low concentrations of native cytidine 5′-diphosphocholine (CDP-Cho) and d 9-CDP-Cho in both cell lines show that CDP-Cho is the limiting metabolite in the two models. The turnovers (percentage of each d 9-Cho compound in its respective pool, i.e. native + labelled) were lower in radioresistant cells for all Cho compounds, suggesting a global PtdCho metabolism more active in radiosensitive cells that could be related to their higher proliferation rate. HILIC-ESI-MS/MS applied to the analysis of hydrophilic and lipophilic choline (Cho) compounds in radioresistant (RR) and radiosensitive (RS) glioblastoma cell lines incubated for 8h with d9-Cho showed (i) higher uptake of d9-Cho and formation of d9-phosphocholine (d9-PCho) in the RR cell line; (ii) very low and similar amounts of d9-cytidine 5’-diphosphocholine (d9-CDP-Cho) in both cell lines suggesting that this compound is the limiting metabolite; and (iii) lower formation of d9-phosphatidylcholines (d9-PtdCho) in the RR cell line.Keywords
This publication has 22 references indexed in Scilit:
- Profiling of lipids in Leishmania donovani using hydrophilic interaction chromatography in combination with Fourier transform mass spectrometryRapid Communications in Mass Spectrometry, 2010
- Exciting New Advances in Neuro-Oncology: The Avenue to a Cure for Malignant GliomaCA: A Cancer Journal for Clinicians, 2010
- Lipidomics: a mass spectrometry based systems level analysis of cellular lipidsCurrent Opinion in Chemical Biology, 2009
- Radiation-induced Akt activation modulates radioresistance in human glioblastoma cellsRadiation Oncology, 2009
- Metabolomic applications of HILIC–LC–MSMass Spectrometry Reviews, 2009
- Mass spectrometry: from proteomics to metabolomics and lipidomicsChemical Society Reviews, 2009
- Analysis of acetylcholine, choline and butyrobetaine in human liver tissues by hydrophilic interaction liquid chromatography-tandem mass spectrometryJournal of Pharmaceutical and Biomedical Analysis, 2008
- HDJ-2 as a Target for Radiosensitization of Glioblastoma Multiforme Cells by the Farnesyltransferase Inhibitor R115777 and the Role of the p53/p21 PathwayCancer Research, 2006
- The emerging field of lipidomicsNature Reviews Drug Discovery, 2005
- Farnesyltransferase inhibitor, R115777, reverses the resistance of human glioma cell lines to ionizing radiationInternational Journal of Cancer, 2002